OverviewSuggest Edit

Cord Blood America, Inc.(CBAI), through its CorCell program and its wholly owned subsidiary CorCell Companies, Inc., provides cord blood and cord tissue stem cell services. Cryogenically preserved cord blood stem cells have already been used to treat major diseases, including leukemia, severe anemia, metabolic and blood disorders and immune deficiencies. In addition, the umbilical cord, which at birth traditionally has been thrown away, contains a rich store of stem cells.

TypePublic
Founded1999
HQLas Vegas, US
Websitecordblood-america.com

Locations

Cord Blood America is headquartered in
Las Vegas, United States

Location Map

Latest Updates

Employees (est.) (Feb 2019)8(-46%)
Revenue (FY, 2018)$0
Share Price (Oct 2017)$0 (+15%)

Cord Blood America Office Locations

Cord Blood America has an office in Las Vegas
Las Vegas, US (HQ)
1857 E Helm Ave
Show all (1)

Cord Blood America Financials and Metrics

Cord Blood America Revenue

USD

Net income (Q3, 2019)

(126.3k)

EBIT (Q3, 2019)

(197.6k)

Market capitalization (8-Oct-2018)

8.5m

Cash (30-Sept-2019)

11.4m
Cord Blood America's current market capitalization is $8.5 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

5.7m6.0m6.0m4.3m5.3m3.3m

Revenue growth, %

(28%)21%(37%)

Cost of goods sold

1.9m1.8m2.0m1.4m1.9m904.9k

Gross profit

3.8m4.2m4.0m3.0m3.4m2.4m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

1.4m1.5m1.6m1.8m1.5m1.5m1.5m1.5m1.4m1.5m1.2m1.3m1.4m1.4m986.3k793.2k775.0k745.9k746.4k747.7k

Cost of goods sold

459.8k436.8k434.8k518.0k422.5k440.0k474.1k474.9k439.2k473.3k423.1k402.5k508.7k545.5k340.3k201.5k172.9k170.9k176.0k162.2k

Gross profit

970.6k1.1m1.1m1.3m1.1m1.0m1.0m1.0m976.3k1.1m774.2k875.6k904.3k885.0k646.0k591.8k602.1k575.0k570.4k585.5k

Gross profit Margin, %

68%71%72%71%72%70%68%68%69%69%65%69%64%62%65%75%78%77%76%78%
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

196.4k393.8k708.8k750.9k789.0k926.2k1.1m12.4m

Accounts Receivable

213.4k181.7k155.7k287.6k349.9k61.7k11.9k

Prepaid Expenses

91.8k91.9k410.3k79.7k151.9k146.5k113.3k

Inventories

58.4k
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(6.0m)(1.1m)(3.0m)240.1k437.9k102.2k(3.1m)

Depreciation and Amortization

790.2k792.7k787.3k474.5k399.9k363.2k5.4k9.1k

Inventories

(66.6k)(18.5k)(45.4k)

Accounts Payable

116.5k23.9k16.0k(1.5k)219.9k(261.5k)
USDY, 2019

Financial Leverage

1 x
Show all financial metrics

Cord Blood America Online and Social Media Presence

Embed Graph

Cord Blood America Frequently Asked Questions

  • When was Cord Blood America founded?

    Cord Blood America was founded in 1999.

  • How many employees does Cord Blood America have?

    Cord Blood America has 8 employees.

  • Who are Cord Blood America competitors?

    Competitors of Cord Blood America include PacifiCord, Clementia Pharmaceuticals and Synthace.

  • Where is Cord Blood America headquarters?

    Cord Blood America headquarters is located at 1857 E Helm Ave, Las Vegas.

  • Where are Cord Blood America offices?

    Cord Blood America has an office in Las Vegas.

  • How many offices does Cord Blood America have?

    Cord Blood America has 1 office.